59 related articles for article (PubMed ID: 19649937)
21. Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology.
Hilleman MR; Gerety RJ; Ellis RW
Dev Biol Stand; 1987; 68():5-7. PubMed ID: 3691963
[No Abstract] [Full Text] [Related]
22. Chitosan-based systems for the delivery of vaccine antigens.
Arca HC; Günbeyaz M; Senel S
Expert Rev Vaccines; 2009 Jul; 8(7):937-53. PubMed ID: 19538118
[TBL] [Abstract][Full Text] [Related]
23. [Progress in the development of vaccines against helminths].
Kozak M; Kołodziej-Sobocińska M
Wiad Parazytol; 2009; 55(2):147-56. PubMed ID: 19670530
[TBL] [Abstract][Full Text] [Related]
24. [Current perspectives in vaccine preparation].
Andersen H; Christiansen G; Christiansen C
Ugeskr Laeger; 1983 Aug; 145(34):2580-4. PubMed ID: 6577744
[No Abstract] [Full Text] [Related]
25. Application of radiation technology in vaccines development.
Seo HS
Clin Exp Vaccine Res; 2015 Jul; 4(2):145-58. PubMed ID: 26273573
[TBL] [Abstract][Full Text] [Related]
26. Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.
Lokhov PG; Balashova EE
J Cancer; 2010 Nov; 1():230-41. PubMed ID: 21151581
[TBL] [Abstract][Full Text] [Related]
27. Antigens yield to new technology.
Wakelin D
Immunol Today; 1983 Nov; 4(11):310-1. PubMed ID: 25290712
[No Abstract] [Full Text] [Related]
28. Recombinant DNA technology for the preparation of subunit vaccines.
Bachrach HL
J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
[TBL] [Abstract][Full Text] [Related]
29. Single-cycle adenovirus vectors in the current vaccine landscape.
Barry M
Expert Rev Vaccines; 2018 Feb; 17(2):163-173. PubMed ID: 29251011
[TBL] [Abstract][Full Text] [Related]
30. A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination.
Crosby CM; Weaver EA; Khare R; Barry MA
Virol Rep; 2015 Dec; 5():47-55. PubMed ID: 26550557
[TBL] [Abstract][Full Text] [Related]
31. Applications of, and future challenges for, genetic vaccines.
Johnston SA; Qu BX; McGuire M; Stemke-Hale K; Sykes K
Dev Biol (Basel); 2000; 104():3-8. PubMed ID: 11713821
[TBL] [Abstract][Full Text] [Related]
32. Plant vaccines: edible, but how credible?
CVI Forum; 1996 Aug; (12):10-3. PubMed ID: 12321482
[TBL] [Abstract][Full Text] [Related]
33. Genetic immunization: applying recombinant DNA technology in the immune system to develop new vaccines.
Barry MA
Curr Opin Drug Discov Devel; 1999 Mar; 2(2):118-28. PubMed ID: 19649937
[TBL] [Abstract][Full Text] [Related]
34. Expression library immunization to discover and improve vaccine antigens.
Barry MA; Howell DP; Andersson HA; Chen JL; Singh RA
Immunol Rev; 2004 Jun; 199():68-83. PubMed ID: 15233727
[TBL] [Abstract][Full Text] [Related]
35. [Genetic immunization--"the biological equivalent of cold fusion"?].
Fomsgaard A
Ugeskr Laeger; 1995 Sep; 157(36):4932-6. PubMed ID: 7676526
[TBL] [Abstract][Full Text] [Related]
36. A Forum brief on nucleic acid vaccines.
CVI Forum; 1994 Aug; (7):7-10. PubMed ID: 12294222
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
